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Abstract Zinc finger protein, X-linked (ZFX) is a transcrip-
tional factor involved inmany physiological processes such as
embryonic stem cell survival and self-renewal. Though ZFX
dysfunctions have been identified in variant human diseases
and especially in cancers, its pathological roles have not been
fully addressed. Here, we explored the relationship between
ZFX expression and squamous cell carcinoma (SCC) of the
tongue. We found that ZFX expression was significantly
higher in tongue SCC tumors as compared to tumor-adjacent
normal tissues. Furthermore, ZFX knockdown impeded cell
proliferation, impaired colony formation ability, and lead to
cell cycle arrest while induced cell apoptosis in human tongue
squamous cell carcinoma cell line Tca-8113. Our results pro-
vide evidence suggesting that ZFX overexpression is associ-
ated with the development of tongue SCC and ZFX knock-
down is a potential treatment for tumor suppression.
Keywords Oral squamous cell carcinorma . Zinc finger
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Introduction
Tongue squamous cell carcinoma (SCC) is the most common
malignant type in head and neck squamous cell carcinoma
(HNSCC), which is among the top ten leading cancers world-
wide [1]. Though remarkable progress has been achieved in
clinical and basic research in the past three decades, the 5-year
survival rate of tongue SCC patients showed little improve-
ment and remained about 50 % [2]. Another major problem is
that most tongue SCC cases showed lymph node metastasis at
diagnosis, which indicated poor prognosis, and effective treat-
ment are still underway at present. Though multiple factors
including drinking and smoking have been implicated in the
development and progression of tongue SCC [3], molecular
signals and factors involved in tumorigenesis remain to be
determined. Exploring novel molecules involved in tongue
SCC will provide valuable insights for better diagnosis and
treatment of human tongue SCC in future clinical studies.
Cys2His2 zinc finger (C2H2-ZF) proteins are the major
class of DNA-binding proteins and have been implicated in
diverse biological processes such as cell proliferation differ-
entiation and cell survival while their dysfunctions have been
linked to multiple human diseases including variant types of
cancer [4]. Zinc finger protein, X-linked (ZFX) which is
encoded by X-linked ZFX gene is a C2H2-ZF transcriptional
factor composed of three functional domains including a
DNA-binding domain containing 13 C2H2-type zinc fingers,
an acidic transcriptional activation domain, and a nuclear lo-
calization sequence. It has been shown previously that ZFX is
critical for the survival and self-renewal of embryonic and
hematopoietic stem cells [5, 6]. In consistent with the role of
C2H2-ZF proteins in cancer development, previous studies
from our lab have shown that ZFX is aberrantly upregulated
in human laryngeal squamous cell carcinoma and ZFX knock-
down impaired cancer cell proliferation and apoptosis [7].
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Furthermore, ZFX protein has been implicated in acute mye-
loid leukemia (AML) and acute T-lymphoblastic leukemia (T-
ALL) [8]. However, the relationship between ZFX and tongue
SCC remains poorly understood.
As both tongue SCC and laryngeal squamous cell carcino-
ma belong to HNSCC, here we examined the expression sta-
tus of ZFX and unraveled significant expression differences
between tumors and adjacent normal tissues derived from
tongue SCC patients. In accord with previous studies showing
that ZFX expression is increased in tumors, ZFX overexpres-
sion was observed in tongue SCC samples. Furthermore, ZFX
expression in human tongue squamous cell carcinoma cell line
Tca-8113 was inhibited efficiently by lentiviral-based small
interference RNA (siRNA) strategy, and the impact of ZFX
knockdown on cell proliferation, colony formation, cell cycle,
and cell survival was investigated extensively, confirming the
pathological role of ZFX for tongue SCC development and
progression. So, our results provide confidential evidence that
ZFX is quite a promising target for tongue SCC treatment.
Materials and methods
Patients, tumor samples, and immunohistochemistry (IHC)
staining
This study was approved by the Research Ethics Board, and
informed consent was obtained from all patients. A consecu-
tive series of 30 tongue squamous cell carcinoma patients
including 21 male and 9 female patients (between 24 and
85 years old with an average 59.7 years old) who underwent
surgery between March 2011 and December 2013 was in-
volved in this study. Patients could be classified according to
tumor TNM stage system and shown in Table 1. None of the
patients were treated with radiotherapy, chemotherapy, or oth-
er therapies before surgery. Specimens of tumor and of normal
adjacent tissues were obtained, frozen in liquid nitrogen im-
mediately, and stored at −80 °C for further analysis. ZFX
immunohistochemical staining was performed as described
previously [9]. Briefly, 4.0-μm-thick paraffin-embedded
tissue sections were prepared and incubated with NBP1-
80582 ZFX antibody purchased from Novus Company. Stain-
ing was done with an EliVisionTM plus kit (Fuzhou Maixin
Biotech. Co., Ltd). Then, in each slice, five fields were select-
ed randomly under high magnification (400×). The mean op-
tical density (OD) of ZFX positive cells was counted in each
field, and then, OD value of five fields was averaged for ZFX
expression in each slice. OD value of each specimen was
calculated as above, and paired t test was used to for OD value
comparation between tumor and normal adjacent tissue sam-
ples. Leica dc300f microscope, Leica IM50 picture collecting
system, and Leica Qwin software were used here.
Production of lentivirus expressing ZFX-siRNA
To inhibit ZFX expression, lentivirus expressing siRNA
targeting ZFX specifically was produced as described previ-
ously [10]. Briefly, siRNA (siRNA sequence: gaGCCTGA
GAATGATCATGGA) specifically targeting human ZFX
gene (ZFX-siRNA) was designed while scrambled siRNA
(scr-siRNA) with the following sequence was used as the
negative control: TTCTCCGAACGTGTCACGT. To con-
struct lentivirus expressing ZFX- or scr-siRNA, complemen-
tary single-strand DNA oligonucleotides were synthesized,
annealed, and then inserted into lentiviral vector pGCSIL-
GFP (GeneChem, Shanghai, China). Lentivector expression
system (GeneChem, Shanghai, China) was selected to prepare
desired lentivirus. Human tongue squamous cell carcinoma
cell line Tca-8113 was selected and infected with lentivirus
expressing ZFX- or scr-siRNA to determine the knockdown
efficiency at RNA and protein level by real-time PCR and
Western blot.
Bromodeoxyuridine (BrdU) incorporation assay
Cell proliferation was assessed using BrdU incorporation as-
say. Human tongue squamous cell carcinoma cell line Tca-
8113 was cultured and infected with lentivirus expressing
ZFX or scrambled siRNA and incubated for another 48 h.
Cells were then resuspended and seeded into 96-well plates
at the proper density and cultured for another 1 or 4 days.
Then, BrdU reagents were added with 1:100 dilution (10 μl/
well). After 2–24 h, BrdU incorporation was analyzed using a
BrdU Cell Proliferation ELISA kit (Cat. No. 11647229001,
Roche Applied Science) following the manufacturer’s instruc-
tions. Briefly, cell fixation was performed using FixDenat
(200 μl/well) for 30 min and blocked with 5–10 % BSA for
another 30 min at room temperature. Then, cells were treated
with diluted anti-BrdU-POD for 90 min at room temperature.
Cells were incubated with substrate solution for 5–30 min in
the dark after washing three times with washing buffer. After
color development, the absorbance of the samples was mea-
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MTT assay
Cell proliferation status was determined by MTT assay. Hu-
man tongue squamous cell carcinoma cell line Tca-8113 was
infected with lentivirus expressing ZFX-siRNA or scrambled
siRNA and incubated to reach logarithmic phase. Cells were
then digested and resuspended thoroughly. Cell number was
then counted using a hemocytometer, and 3000 cells per well
were added in 96-well plates and cultured at 37 °C in a 5 %
CO2 incubator. Cell proliferation was monitored for continu-
ous 5 days with MTT assay. Each well was incubated with
20 μl of MTT solution (5 mg/ml) for 4 h. The culture medium
was discarded, and 150 μl DMSO was added to dissolve
formazan. 96-well plate was shaken for 5–10 min, and absor-
bance at 490/570 nm was examined with a microplate reader.
Cell apoptosis measurement
Cell apoptosis was detected using annexin V-APC apoptosis
detection kit (eBioscience, 88–8007) and measured with flow
cytometry. In brief, Tca-8113 cells were infected with lentivi-
rus expressing ZFX-siRNA or scrambled siRNA and incubat-
ed at 37 °C for 4 days. After collection and washing with
phosphate-buffered saline (PBS) buffer, cells were resuspend-
ed with staining buffer at a final density of 1×106–1×107/ml.
Then, 5 μl annexin V-APC was added to 100 μl cell suspen-
sions and incubated at room temperature in the dark for 10–
15 min. Finally, cells were analyzed with FACS Calibur
(Becton-Dickinson, USA) to determine cell apoptosis profiles.
RNA extraction, reverse-transcription, and real-time
quantitative PCR
To determine the siRNA efficiency, Tca-8113 cells were in-
fected with lentivirus expressing either ZFX-siRNA or scram-
bled siRNA and cultured for another 48 h. Then, total RNA
was isolated using Trizol reagent (Invitrogen) according to the
manufacturer’s instructions. M-MLV reverse transcriptase
(Promega) and Oligo dT primers (Sangon, Shanghai) were
used for reverse transcription to produce cDNAs. Briefly, a
10 μl mixture containing 2 μg RNA, 0.5 μg Oligo dT primers
was incubated at 70 °C for 10 min and then cooled on ice.
Then, buffer, reverse transcriptase, RNase inhibitor, and
dNTPs were added to a final 20 μl mixture and incubated at
42 °C for 1 h. ZFX expression was quantified with real-time
quantitative PCR using a Real-Time PCR machine TP800
(Takara). Here, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as an internal control. Primers used in
real-time PCR were as follows: GAPDH for 5′-TGACTTCA
ACAGCGACACCCA-3′; GAPDH reverse: 5′-CACCCTGT
TGCTGTAGCCAAA-3′; ZFX for 5′-GGCAGTCCACAG
CAAGAAC-3′; ZFX reverse: 5′-TTGGTATCCGAGAAAG
TCAGAAG-3′. Messenger RNA (mRNA) levels of ZFX
were normalized against GAPDH, and the comparative CT
method was chosen to quantify ZFX expression in Microsoft
Excel.
Colony formation assay
In brief, lentivirus expressing either ZFX-siRNA or scrambled
siRNA was added into Tca-8113 cells. After incubation for
another 48 h, cells reached the logarithmic phase and were
harvested. Then, cell density was calculated using a hemocy-
tometer, and 800 cells per well were plated in triplicate into 6-
well plates. After culturing in a 5%CO2 incubator at 37 °C for
another 14 days, cells were fixed with paraformaldehyde for
30–60 min and then stained with GIEMSA for 20 min. Mi-
cropublisher 3.3RTV (Olympus) was used for imaging cap-
ture, and then, cell colonies under each condition were count-
ed and analyzed.
Cell cycle analysis by flow cytometry
Cell cycle process was analyzed using flow cytometry as de-
scribed in previous studies with slight modifications [11]. In
brief, lentivirus expressing either ZFX-specific siRNA or
scrambled siRNA was added into human tongue squamous
cell carcinoma cell line Tca-8113. After incubation for another
4 days, cells were resuspended and seeded in 6-cm dishes.
Cells were collected and fixed with ice-cold 70% alcohol after
reaching approximately 80 % coverage. 40×PI stock
(2 mg/ml), 100×RNase stock (10 mg/ml), and 1×PBS buffer
at a dilution of 25:10:1000 were used for subsequent cell
staining. Then, flow cytometry machine FACS Calibur
(Becton-Dickinson, USA) was used to perform cell cycle
analysis. At least 1×106 cells per sample were used for cell
cycle analysis, and experiments were replicated for three times
independently.
Western blot
In brief, Tca-8113 cells were washed with TBST buffer and
then treated with lysis buffer. Appropriate protein lysates were
mixed with 2× loading buffer, separated on 10–12 % SDS-
PAGE and transferred to PVDF membranes (Amersham),
which was further blocked with 5 % dissolved milk buffer
for 2 h at room temperature and incubated overnight with
specific primary antibodies including anti-cleaved caspase 3
(Cell Signaling #9664), anti-cleaved PARP (Cell Signaling
#5625), and anti-GAPDH. After washing three times with
TBST buffer, corresponding secondary antibodies coupled to
HRP from Santa Cruz were added and ECL-Plus kit
(Amersham Biosciences) was used for signal detection.
Tumor Biol. (2015) 36:6103–6112 6105
Results
Increased ZFX expression in tumors of tongue SCC patients
Initially, tumor tissues and adjacent tumor tissues collected
from tongue SCC patients were examined and confirmed
using hematoxylin and eosin (H&E) staining (representative
images, Fig. 1a–b). Then, ZFX expression status was ex-
amined using immunohistochemistry (IHC) staining in
tumor and adjacent normal tissues (representative im-
ages, Fig. 1a–b). ZFX expression were further quanti-
fied depending on the optical density of IHC signals
and compared between tumors and adjacent normal tis-
sues. Results showed that ZFX expression in tumor
tissues was significantly higher than that in adjacent
normal tissues (Fig. 2).
ZFX expression was suppressed using lentiviral-mediated
siRNA strategy in Tca-8113 cell lines
As described above, ZFX expression in human tongue SCC
samples was significantly higher than that in normal adjacent
tissues, which implicated that ZFX might be a pathological
factor involved in human tongue SCC development. Tca-8113
cell line from human tongue squamous cell carcinoma was
selected for ZFX functional analysis in human tongue SCC
development in vitro. And, lentiviral-mediated small interfer-
ing RNA (siRNA) strategy was employed to inhibit ZFX
Fig. 1 Expression of ZFX proteins in tumors and adjacent normal tissues
from tongue SCC patients using IHC immunohistochemistry (IHC) and
H&E staining. T tumor tissues, A adjacent normal tissues, P11 patient 11,
P10 patient 10, P15 patient 15. a Sample micrographs of ZFX IHC and
H&E staining in tongue SCC tumor tissues and adjacent normal tissues
from patient 11 (left, 100×, right, 400×). b Sample micrographs of ZFX
staining and H&E staining in tongue SCC tumor tissues and adjacent
normal tissues from patient 10 and patient 15 (left, patient 10, right,
patient 15; magnification, 400×)
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expression in Tca-8113 cells. Lentivirus expressing either scr-
siRNA or ZFX-siRNA was generated and added into Tca-
8113 cells. GFP expression could be observed in more than
95 % of cells 48 h after lentivirus tranfection (Fig. 3a). After
48 h incubation, total RNAs were extracted from cells infected
with lentivirus expressing scr-siRNA or ZFX-siRNA and
ZFX expression status at mRNA level was determined using
real-time quantitative PCR. It was shown that ZFX expression
in cells infected with ZFX-siRNA was downregulated by
73 % as compared to cells infected with scr-siRNA
(Fig. 3b). Our results provided strong evidence showing that
lentiviral-mediated siRNA strategy could inhibit ZFX expres-
sion efficiently in Tca-8113 cells, which provided a reliable
method for ZFX functional analysis in subsequent
experiments.
ZFX knockdown inhibited cell proliferation inTca-8113 cells
Sustained proliferation ability is the most fundamental hall-
mark of cancer cells. So, here, Tca-8113 cells were treated
with lentivirus expressing ZFX- or scr-siRNA, and BrdU in-
corporation assay was employed to investigate the impact of
ZFX knockdown on cell proliferation ability. BrdU incorpo-
ration ratio was determined after 24 h of cell seeding, and it
was shown that initial proliferation ability of Tca-8113 cells
with different treatment was comparable (Fig. 4a, day 1).
However, after 4 days of lentivirus infection, ZFX-specific
siRNA resulted in remarkably impaired cell proliferation with
about 24% reduction of BrdU incorporation ratio (Fig. 4a, day
4). Cell proliferation status was further analyzed with MTT
assay for continuous 5 days. At the first day, cell proliferation
was comparable in Tca-8113 cells treated with either scr-
siRNA or ZFX-siRNA. However, in the following 4 days, cell
proliferation was significantly impaired in cells treated with
ZFX-siRNA as compared to cells treated with scr-siRNA
(Fig. 4b). Our results revealed that when ZFX was inhibited,
Tca-8113 cell proliferation was suppressed significantly.
Impairment of colony formation ability in Tca-8113 cells
by ZFX knockdown
Clonogenic ability is critical for tumor outgrowth and expan-
sion and could be determined using colony formation assay,
which examines the ability of a single cell to form a colony
containing at least 50 cells. And here, it was shown that small-
er clones containing sparse and fewer cells were formed by
Tca-8113 cells targeted by ZFX-siRNA as compared to clones
formed by Tca-8113 cells targeted by scr-siRNAs (Fig. 4c, left
panel). Furthermore, fluorescence in clones formed by ZFX-
siRNA-treated cells was significantly weaker than that in
Fig. 2 Expression quantification of ZFX proteins in tumor and adjacent
normal tissues. Quantification of ZFX expression in tumors and tumor-
adjacent normal tissues depending on optical density of ZFX positive
signals in IHC slices
Fig. 3 ZFX knockdown by lentiviral-based siRNA strategy. a Represen-
tative pictures of Tca-8113 cells infected with lentivirus expressing either
scr-siRNA or ZFX-siRNA for 48 h. b ZFX expression at mRNA level in
cells infected with lentivirus expressing either scr-siRNA or ZFX-siRNA
was analyzed using real-time quantitative PCR method. GAPDH was
used as internal control, and data shown here is the mean±S.D. of three
independent experiments (***p<0.001)
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clones formed by scr-siRNA-treated cells (Fig. 4c, right pan-
el). And, colony formation assay showed that an average of
224 clones formed in scr-siRNA-treated cells while the clone
number was reduced to 185 in ZFX-siRNA-treated cells
(Fig. 4d–e). These results revealed that ZFX knockdown
inhibited clone formation in Tca-8113 cells, which indicated
that ZFX is essential for clonogenic ability of human tongue
squamous cell carcinoma cells.
Cell cycle disruption by ZFX knockdown
Impairment of cell proliferation by ZFX knockdown promot-
ed us to examine the relationship between ZFX and cell cycle
progression in Tca-8113 cells. Cells were treated with lentivi-
rus expressing either scr-siRNA or ZFX-siRNA, and cell cy-
cle was analyzed with flow cytometry (Fig. 5a). Results
showed that significant cell cycle arrest at the G2/M phase
was induced by ZFX knockdown, as the percentage of G2/
M phase cells increased from 7.59 to 12.27 % with ZFX-
siRNA treatment. In addition, cell percentage at S phage was
significantly decreased from 40.85 to 35.08 %, but cell per-
centage at G1 phase changed little (Fig. 5b). Taken together,
these data showed that cell cycle progression was disrupted by
ZFX knockdown and indicated that ZFX knockdown-induced
cell proliferation impairment might be partially attributed to
cell cycle arrest.
Fig. 4 Impairment of cell proliferation and colony formation ability in
Tca-8113 cells infected with lentivirus expressing ZFX-siRNA. a BrdU
incorporation assay was used to analyze the proliferation of Tca-8113
cells infected with lentivirus expressing either scr-siRNA or ZFX-
siRNA. The BrdU incorporation ratio is represented as fold changes of
absorbance at 450 nm (ODBrdU/fold). Day 1 means the BrdU
incorporation ratio in cells 24 h after lentivirus infection, and day 4
means the BrdU incorporation ratio 4 days after lentivirus infection.
Data here is the mean±S.D. of three independent experiments
(*p<0.05). b Cell proliferation of Tca-8113 cells infected with
lentivirus expressing either scr-siRNA or ZFX-siRNA was further
determined by MTT assay for continuous 5 days. Data shown here is
the mean±S.D. from three independent experiments (*p<0.05). c
Representative pictures of clones formed by Tca-8113 cells infected
with lentivirus expressing either scr-siRNA or ZFX-siRNA. Differential
interference contrast (DIC, left panel) and GFP (right panel) pictures
were shown. d Representative pictures of colony formation assay in 6-
well plate for Tca-8113 cells infected by lentivirus expressing either scr-
siRNA or ZFX-siRNA. e Quantification of clone number in Tca-8113
cells infected by lentivirus expressing either scr-siRNA or ZFX-siRNA.
Data shown here is the mean±S.D. of clone numbers from three
independent experiments (**p<0.01)
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Reduction of ZFX induced apoptosis in Tca-8113 cells
In addition to uncontrolled proliferation, apoptosis evasion is
another fundamental trait of cancer cells. To examine the im-
pact of ZFX knockdown on cell apoptosis, Tca-8113 cells
were infected with lentivirus expressing ZFX-specific or
scrambled siRNA. After 4 days of lentivirus infection, the
apoptosis of cells was determined with annexin V-APC assay
and analyzed by flow cytometry (Fig. 6a). Apoptosis was
observed in 2.76 % of Tca-8113 cells infected with scrambled
siRNA and increased to 3.5 % in cells infected with ZFX-
specific siRNA (Fig. 6b). Furthermore, Western blot anal-
ysis was performed to determine whether any apoptosis-
associated genes were involved in the process of ZFX-
induced cell apoptosis in Tca-8113 cells. It was shown
that ZFX knockdown led to the upregulation of cleaved
caspase 3 and PARP proteins (Fig. 6c), which were both
critical for the induction of cell apoptosis. Taken
together, these data suggests that ZFX plays an anti-
apoptotic role in Tca-8113 cells.
Discussion
ZFX protein is a C2H2-ZF protein identified as a transcrip-
tional factor belonging to ZFYprotein family. Its involvement
in cancer development has been explored extensively. For
example, ZFX overexpression has been observed in prostate
cancer [12], gastric cancer [13–15], human gliomas [16, 17],
non-small-cell lung cancer (NSCLC) [18], breast cancer [19],
and so on. Studies from our lab also showed that ZFX is
involved in human laryngeal squamous cell carcinoma
(LSCC), a subgroup of cancer of HNSCC, and ZFX knock-
down impaired the cell proliferation and induced apoptosis in
LSCC Hep-2 cells [7]. Here, we unraveled that ZFX expres-
sion increased significantly in tongue SCC tumors, another
Fig. 5 Cell cycle disruption in
Tca-8113 cells infected with
lentivirus expressing ZFX-
specific siRNA. a Cell cycle
analysis by flow cytometry and
representative images were
shown. b Cell cycle distribution
in Tca-8113 cells infected with
lentivirus expressing scr-siRNA
or ZFX-siRNA. Data shown here
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type of cancer of HNSCC, as compared to tumor-adjacent
normal tissues. So, these results suggest that ZFX upregula-
tion in tumors is quite common and ZFX as a potential bio-
marker for cancer diagnosis should be investigated in the
future.
Tongue SCC accounts for about 90 % of HNSCC, which
ranks among the top ten cancers worldwide. However,
disrupted molecular factors underlying tongue SCC initiation
and progression remain poorly understood, which hindered
the development of efficient strategies for tongue SCC pre-
vention, diagnosis, prognosis, and treatment. Here, we quan-
tified ZFX expression in tissue samples from tongue SCC
patients by OD measurement rather than by pathologists, as
OD measurement will provide objective quantifications about
ZFX expression. And, our discovery of ZFX overexpression
in tongue SCC samples expanded our understanding about
molecular mechanisms of tongue SCC. Furthermore, in vitro
studies in Tca-8113 cells revealed that ZFX inhibition by
lentivirus-based siRNA strategy delayed cell proliferation,
impaired colony formation ability, and lead to cell cycle arrest
while promoted cell apoptosis, suggesting its essential role for
tumor cell growth and survival. However, the underlying
mechanisms about colony formation ability impairment by
ZFX knockdown remain elusive, though it was shown in this
study that ZFX expression is essential for colony formation.
In-depth analysis of ZFX-associated molecular pathways will
provide more valuable insights in tongue SCC and HNSCC
development.
Indeed, it has been reported that ZFX is the target gene of
miR-144, and in consistent with the oncogenic functions of
ZFX, miR-144 expression was diminished significantly in
gastric cancer and non-small-cell lung cancer [14, 18], sug-
gesting that disrupted miR-144-ZFX axis may be underlying
the development of variant tumors. Studies also showed that
miR-144 overexpression could inhibit the tumor growth and
induce cell apoptosis in NSCLC which is in accordance with
the effect of ZFX knockdown. In addition to the upstream
effector miR-144, downstream effectors of ZFX were also
Fig. 6 Apoptosis induction in
Tca-8113 cells infected with
lentivirus expressing ZFX-
specific siRNA. a Cell apoptosis
by annexin-V staining was
analyzed with flow cytometry.
b Cell apoptosis in Tca-8113 cells
infected with lentivirus
expressing scr-siRNA or ZFX-
siRNA. Apoptosis was
determined with annexin V-APC
assay and analyzed using flow
cytometry. Data shown here is the
mean±S.D. of cell percentage in
apoptosis from three independent
experiments (**p<0.01). c
Western blot analysis of
apoptosis-associated genes in
Tca-8113 cell lysates infected
with lentivirus expressing
scr-siRNA or ZFX-siRNA.
GAPDH was used as internal
control
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investigated in other studies. It has been reported that ZFX
knockdown in diverse tumor types including gliomas [17],
NSCLC [20], LSCC [7], breast cancers [19], and gastric can-
cer [13] all led to hypophosphorylation of Akt, extracellular
signal-regulated kinase 1/2 (ERK1/2), or MEK1/2 except for
ERK2 hyperphosphorylation in breast cancer cells [19]. These
results indicated that ZFXwas critical for the activation of Akt
and MAPK signaling pathways, which were two important
pathways for cell survival. What’s more, ZFX knockdown
resulted in the downregulation of anti-apoptotic factor such
as bcl-2 and upregulation of apoptotic factors including bax,
caspase1, 3, 9 in diverse cancers [7, 12, 13, 17, 19, 20]. In our
study, we also confirmed that two apoptosis-related proteins
cleaved caspase 3 and PARP were both upregulated in Tca-
8113 cells treated with ZFX-specific siRNA. These results
were all in consistent with the phenomenon that ZFX knock-
down induces cell apoptosis in Tca-8113 cells and provided
valuable insights for the underlying mechanisms of ZFX-
mediated cell apoptosis. Furthermore, it has been revealed that
cell cyle factors such as cyclin D1 and cyclin B1 was down-
regulated by ZFX knockdown in multiple cancer types [17,
19, 20], which might account for the cell cycle disruption in
Tca-8113 cells treated with ZFX-siRNA. Indeed, ZFX knock-
down induced G1 phase cell cycle arrest in Tca-8113 cells,
which is in consistent with previous cell cycle results in PC-3
cells [12], SGC7901 cells [13], H1299 cells [20], MDA-MB-
231 cells [19], U87, and U373 cells [21], and in contrast to
results in MGC803 cells [13] and Hep-2 cells [7], in which S
phase cell cycle arrest was induced by ZFX knockdown. It has
been demonstrated that cyclin D1 and cyclin E1 were essential
for G1/S phase transition [22, 23] while cyclin A2 was in-
volved in S-phase process [24], so it is quite likely that cyclin
E1 or cyclin D1 function was disrupted in Tca-8113 cells by
ZFX knockdown, which has been confirmed in SGC7901
cells [13], U87, and U373 cells [17] treated with ZFX-siRNA.
It should be noticed that though ZFX functions have been
investigated in multiple cancers, very little research focused
on the roles of ZFX in HNSCC or tongue squamous cell
carcinoma. So, our future studies will focus on the upstream/
downstream pathways of ZFX in vitro and in vivo to provide
more insights into the underlying mechanisms about HNSCC
or tongue squamous cell carcinoma. A thorough and compre-
hensive analysis about ZFX in different cancers are also need-
ed, and such analysis will help to clarify the distinct and over-
lapping roles of ZFX in different cancers, paving the way for
the development of efficient clinical applications targeting
ZFX.
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